by a mutation in LMNA encoding lamin A/C. Here we show that this mutation causes accumulation of the lamin A precursor protein, a marked alteration of the nuclear architecture and, hence, chromatin disorganization. Heterochromatin domains are altered or completely lost in MADA nuclei, consistent with the finding that heterochromatin-associated protein HP1␤ and histone H3 methylated at lysine 9 and their nuclear envelope partner protein lamin B receptor (LBR) are delocalized and solubilized. Both accumulation of lamin A precursor and chromatin defects become more severe in older patients. These results strongly suggest that altered chromatin remodeling is a key event in the cascade of epigenetic events causing MADA and could be related to the premature-aging phenotype.
brane and the chromatin. A growing number of proteins are known to interact with lamins. Numerous experimental evidences suggest that nuclear lamins are involved in many functions including nuclear positioning and shape, chromatin organization, nuclear envelope assembly/disassembly, DNA replication, and regulation of gene transcriptional activity (18) . The multifunctional aspect of lamins inside cells may explain the large phenotype spectrum observed in patients with a hereditary dysfunction in the lamin A and C gene (27, 31, 36) .
MADA is a specific genetic entity belonging to a class of genetic disorders called "laminopathies," including autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy [EDMD2 (OMIM no. 181350) and EDMD3 (OMIM no. 604929), respectively], limb-girdle muscular dystrophy type 1B (LGMD1B; OMIM no. 159001), Hutchinson-Gilford progeria syndrome (HGPS; OMIM no. 176670), "atypical" Werner syndrome, a dilated cardiomyopathy with conduction defect (CMD1A; OMIM no. 115200), Charcot-Marie-Tooth disorder type 2B1 (CMT2B1; OMIM no. 605588), Dunnigantype familial partial lipodystrophy (FPLD2; OMIM no. 151660), and restrictive dermopathy (RD; OMIM no. 275210) (31) . There is a considerable debate on how mutations in the LMNA gene promote a large number of different phenotypes and why certain mutations can give rise to tissue-specific effects (for a review, see Refs. 5, 22, 23, 24, 28) . Several models have been proposed to explicate this paradox: nuclear fragility, alteration of gene expression patterns, and modification of the relationships between the nuclear membrane and the endoplasmic reticulum (ER) (for a review, see Refs. 27, 36) .
Here, we show that the R527H lamin A/C mutation, which causes MADA, produces accumulation of unprocessed prelamin A, altered distribution of the lamin B receptor (LBR), and destabilization of two heterochromatin-associated proteins, histone H3 methylated at lysine 9 (Me9H3) and heterochromatin protein-1␤ (HP1␤).
MATERIALS AND METHODS
Patient samples. Human fibroblasts were isolated from skin biopsies (dorsal forearm) obtained from three MADA patients and from three control subjects. All biopsies were obtained under institutionally approved protocols (Tor Vergata University, Rome; Gaetano Rummo Hospital, Benevento; Italian Dermatological Institute, Rome, Italy).
MADA patients (MADA-1, female; MADA-2 and MADA-3, males) underwent a skin biopsy at 18 (MADA-1), 35 (MADA-2), and 50 yr of age (MADA-3). All MADA patients were homozygous for the R527H mutation, and they showed the same clinical phenotype without important differences. The three control biopsies were age and sex matched. Fibroblast cultures were established by mechanical and enzymatic methods and cultured in Dulbecco's modified Eagle's-F12 medium (Cambrex) supplemented with 15% fetal bovine serum (Cambrex) and antibiotics. The passage number of each cell type was recorded, and cells were analyzed between passages 2 and 6.
Immunofluorescence staining. Human fibroblasts were grown on coverslips coated with poly-L-lysine, rinsed in PBS, and fixed for 10 min with 4% (wt/vol) paraformaldehyde (in PBS). Cells were permeabilized for 5 min with 0.1% Triton X-100 in 100 mM Tris ⅐ HCl, pH 7.5. Incubation with affinity-purified rat anti-HP1␤ IgG (Mac 353) (46) and rabbit anti-Me9H3 IgG (13) was carried out at room temperature for 1 h. For LBR, prelamin A, and emerin detection, cells were fixed and permeabilized with cold methanol at Ϫ20°C for 7 min, rinsed in PBS, and incubated overnight at 4°C with polyclonal rabbit anti-LBR IgG, polyclonal goat anti-prelamin A antibody (Santa Cruz, sc-6214), or anti-emerin mouse monoclonal antibody (Novocastra). CyTM2-conjugated AffiniPure donkey anti-rabbit IgG (Jackson), FITC-conjugated anti-goat IgG (DAKO), Cy3-conjugated anti-mouse IgG (Sigma), and Texas Red anti-mouse IgG (Calbiochem) were used as secondary antibodies. Hoechst 33342 dye was used at 300 ng/ml. Samples were examined with a Leica fluorescence microscope equipped with a CCD camera. Acquired images were deconvolved using Leica Qfluoro software and processed using Adobe Photoshop.
Western blot analysis. Human fibroblasts were lysed in ice-cold 10 mM Tris ⅐ HCl buffer, pH 7.4, containing 1% Triton X-100, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride (PMFS), and 10 M aprotinin, leupeptin, and pepstatin. For prelamin A detection, 1% SDS was added to the extraction buffer. Blots were probed with anti-lamin A/C (mouse monoclonal; Novocastra), anti-prelamin A (goat polyclonal; Santa Cruz, sc-6214), anti-emerin (mouse monoclonal; Novocastra), antiactin (goat polyclonal; Santa Cruz), anti-HP1␤ (rat monoclonal Mac 353), and anti-Me9H3 (rabbit polyclonal) (13) . Immunoreactive bands were detected with horseradish peroxidase-conjugated secondary antibodies (Pierce) and visualized by enhanced chemiluminescence (Amersham). Densitometry was performed using a Bio-Rad GS-800 calibrated densitometer. Data were reported as percentages of control fibroblast densitometry, and means of three different analyses were calculated.
Electron microscopy. Cell pellets from confluent control and MADA fibroblast cultures were fixed with 2.5% glutaraldehyde-0.1 M phosphate buffer, pH 7.6, for 1 h at room temperature. After treatment with 1% osmium tetroxide in veronal buffer for 1 h, pellets were dehydrated in an ethanol series and embedded in Epon resin. Thin sections stained with uranyl acetate and lead citrate were observed with a Philips EM 400 transmission electron microscope, operated at 100 kV. At least 200 nuclei per sample were observed. Statistical analysis was performed by counting nuclei from three different preparations per each examined sample.
Preparation of nuclear and cytoplasmic fractions and Western Blot analysis. Human fibroblasts were washed twice in PBS, scraped, and collected. The nuclear and cytoplasmic fractions were prepared by suspending cells in 0.3 ml of hypotonic isolation buffer [IB; 10 mM Tris ⅐ HCl, pH 7.6, 10 mM NaCl, 1.5 mM MgCl2, protease inhibitor cocktail (1:1,000; Calbiochem), and 0.1 mM PMSF]. Cells were passed through an ice-cold cylinder cell homogenizer, and nuclei were isolated by centrifuging at 4°C for 15 min at 290 g. Nuclear pellets were washed twice with 0.3 ml of IB, incubated for 30 min on ice in modified IB with 1% Triton X-100, and centrifuged at 12,000 g for 15 min to separate the soluble and the insoluble nuclear fractions. The cytoplasmic supernatant, after two subsequent centrifugations for clearing from cell debris, was detergent extracted by adding 0.5% Nonidet P40 (NP40; Sigma) for 30 min on ice and centrifuged twice (12,000 g at 4°C for 15 min). The cytoplasmic pellet was washed twice in NP40-enriched IB buffer by subsequent centrifugations at 12,000 g for 15 min. Equal amounts of soluble (S) and insoluble (I) proteins from nuclei and cytoplasm were separated on SDS-PAGE in 12% acrylamide gels and blotted.
RESULTS

Cellular level of prelamin A is increased in cells of MADA patients.
Fibroblast cultures from a healthy patient aged 35 yr and three MADA patients aged 18 (MADA-1), 35 (MADA-2), and 50 yr (MADA-3) carrying the same R527H LMNA mutation were analyzed. In particular, we examined by Western blot the LMNA products prelamin A, lamin A, and lamin C. We observed accumulation of prelamin A in fibroblasts derived from MADA patients, with a linear increase of protein amount in older patients (Fig. 1, A and B) . Lamin A level was unaffected in the younger subject and progressively reduced in fibroblasts derived from the older patients (Fig. 1, A and B) . Lamin C level was slightly reduced in MADA-3 fibroblasts ( Fig. 1A) . The expression level of the lamin A/C-binding protein emerin was not altered in MADA fibroblasts (Fig. 1A) .
We then analyzed, by double immunofluorescence, the intracellular localization of prelamin A and emerin in control and MADA nuclei. Control cells ( Fig. 2A ) expressed low amounts of prelamin A that appeared mostly distributed at the nuclear envelope. In marked contrast, MADA nuclei showed accumulation of prelamin A in the nuclear envelope, associated with formation of intranuclear prelamin-labeled structures (Fig. 2,  B-D) . Emerin was localized at the nuclear envelope of MADA-1 and MADA-2 nuclei (Fig. 2, F and G) , while it showed a honeycomb-labeling pattern in MADA-3 cells (Fig.  2H ). Partial colocalization of prelamin A with emerin was observed in MADA-1 and MADA-2 nuclei, but colocalization was lost in most MADA-3 nuclei (Fig. 2, J-L) .
LBR staining of the nuclear envelope is lost in MADA nuclei.
To further investigate whether the observed accumulation of prelamin A in MADA nuclei is related to changes in the distribution of proteins of the nuclear envelope, we studied the localization of LBR in these cells (Fig. 3) . In control fibroblasts, LBR was localized at the nuclear rim (Fig. 3A) . A minor percentage of nuclei (7%) showed intranuclear diffuse staining of LBR (Fig. 3B) . Interestingly, these cells also presented a higher prelamin A level at the nuclear envelope (Fig. 3, F and  G) . In MADA cells, on the contrary, LBR distribution was altered in a high percentage of cells. Thus ϳ50% of MADA-1 nuclei showed both nuclear rim and diffuse nucleoplasmic staining (Fig. 3, C and H) . Nucleoplasmic staining, cytoplasmic localization, and a reduced nuclear envelope labeling of LBR was typical of 60% of MADA-2 (Fig. 3, D and I) and 65% of MADA-3 cells (Fig. 3, E and J) . In some cells, LBR staining at the nuclear rim was almost completely lost (Fig. 3,  E and J) . Both lamin A precursor accumulation at the nuclear envelope (Fig. 2, B-D) and LBR nucleoplasmic localization (Fig. 3, H-J) increased with patient age. Nucleoporins and lamin B were correctly localized in all examined fibroblasts (data not shown).
Heterochromatin organization is lost in MADA nuclei. The ultrastructural morphology of MADA fibroblasts was examined by electron microscopy. This analysis revealed striking nuclear alterations (Fig. 4) . In particular, invaginations of the nuclear envelope or thin papillary projections characterized 15-40% of nuclei (Fig. 4, B and C) . We observed nuclear dysmorphism, irregular thickness of the nuclear lamina (Fig.  4D) , focal absence of peripheral heterochromatin, or complete heterochromatin loss (Fig. 4E) . In some nuclei, projections, invaginations of the nuclear envelope, and peripheral heterochromatin loss were simultaneously observed. A minor percentage of nuclei showed scarce density of interchromatin when compared with controls (Fig. 4F ). All these alterations were absent in control nuclei (Fig. 4A) . The observed nuclear defects were more represented in older MADA cells (Fig. 4G) . In particular, complete absence of heterochromatin from the nuclear periphery ranged from 1-2 to 40% (of 200 nuclei examined) according to patient's age (Fig. 4G) .
Distribution of HP1␤ and Me9H3 is affected in MADA nuclei. To test whether nuclear envelope alterations affect the heterochromatin organization, two major structural components of heterochromatin, the HP1␤ and Me9H3, were studied by double immunofluorescence. In control fibroblasts (Fig. 5, A, E, I , and M), the nuclei were round or ovoid, and the distribution pattern of Me9H3 and HP1␤ Fig. 4 . Electron microscopy analysis of MADA nuclei. Cultured control (A) and MADA fibroblasts (B-F) were fixed with 2.5% glutaraldehyde, included in epoxy resin, and ultra-thin sections were examined by transmission electron microscopy. Ultrastructural alterations observed in MADA nuclei are indicated by arrows. G: percentages of nuclear morphological defects in control (C), MADA-1 (1), MADA-2 (2), or MADA-3 (3). Data are means Ϯ SE of 3 different observations. At least 200 nuclei/ sample were counted. appeared dispersed in multiple small foci filling the whole nuclear area. A strong colocalization of both proteins was evident in merged image (Fig. 5M ). This pattern appeared partially modified in MADA cells in a way that reflected the age of the patient. In particular, in fibroblasts derived from MADA-1 patient, the nuclear morphology was essentially preserved, although a more distinctive localization of Me9H3 and HP1␤ was detected in ϳ15% of cells (Fig. 5, B,  F, J, and N) . Interestingly, these cells also displayed a punctuate DNA distribution, visualized by Hoechst staining (Fig. 5B) , different from the typically more uniform DNA staining of control cells (Fig. 5A) . These fibroblasts accumulated a distinct chromatin structure enriched with heterochromatin proteins, similar to the recently described senescence-associated heterochromatin foci (SAHF) (33) . In 5-10% of MADA-2 (Fig. 5, C, G, K, and O) and in 30 -40% of MADA-3 nuclei (Fig. 5, D, H , L, and P), a pronounced alteration of the nuclear morphology and a different distribution pattern of the investigated heterochromatin proteins were observed. MADA-3 nuclei showed severe signs of degeneration with multiple invaginations and lobulations. In most of the lobules, the colocalization of the proteins was irremediably lost (Fig. 5P) . While Me9H3 was detected inside the papillary extroflessions, no apparent HP1␤ was present in these area.
To further analyze the biochemical features of the two heterochromatin markers, we fractionated fibroblasts derived from control and MADA patients. We first separated the nuclear and the cytoplasmic fractions in the absence of detergent. Subsequently, the two fractions were Triton extracted and centrifuged to isolate the soluble and insoluble pools from each fraction. After separation, we examined, by Western blot, the distribution of the HP1␤ and Me9H3 in these fractions. In control human fibroblasts, both HP1␤ and Me9H3 are mostly found in the insoluble pool of the nuclear pellet (Fig. 6A, lanes 1 and 2) . On the contrary, in fibroblasts derived from MADA-1 and MADA-3 patients, these proteins are differently partitioned and found also in the nuclear soluble pool (Fig. 6A, lanes 3 and 5) . The densitometric analysis of HP1␤ and Me9H3 bands is shown in Fig. 6B . Interestingly, both HP1␤ and Me9H3 accumulation in the soluble pool of the nucleus increased with patient age, varying from 40 -42% in MADA-1 to 48 -50% in MADA-3 fibroblasts. It is worth noting that no immunoreactive pro- teins were present in the cytoplasm, either in control fibroblasts or in MADA cells (data not shown). The fact that the expression level of HP1␤ and the methylation state of H3 histone at lysine 9 were not altered, while the molecules were partially solubilized by Triton X-100 treatment of MADA fibroblasts, is consistent with the finding that heterochromatin in these cells is partly unstructured.
To investigate whether destabilization of HP1␤ and Me9H3 correlates with alteration of the lamina, we analyzed the distribution of prelamin A, lamin A/C, and emerin between supernatant and pellet fractions. In control human fibroblasts, lamin A/C and prelamin A distribute in the nuclear pellet, and emerin is also partly found in the nuclear soluble pool (Fig. 6C,  lanes 1 and 2) . These three molecules are not differently partitioned in MADA cells (Fig. 6C, lanes 3 and 4) .
DISCUSSION
In this report, we have documented the presence of nuclear envelope and chromatin alterations in primary cultured fibroblasts from patients carrying a missense mutation in the LMNA gene (R527H) resulting in MADA phenotype. We demonstrated accumulation of prelamin A, altered stability of heterochromatin proteins HP1␤ and Me9H3, and a redistribution of the nuclear envelope protein LBR in MADA cells. These cells showed evident alterations of the nuclear periphery at the interface between peripheral heterochromatin and the nuclear envelope. Interestingly, the degree of morphological alterations correlated with patient's age. In fact, fibroblasts derived from the oldest patient (MADA-3) revealed a more pronounced irregularity in envelope organization and heterochromatin distribution. This finding further supports a key role of lamins in 1 and 2), MADA-1 (lanes 3 and 4) , and MADA-3 fibroblasts (lanes 5 and 6) were subjected to SDS-PAGE and Western blotting using anti-HP1␤ and anti-Me9H3 antibodies. B: densitometric analysis of HP1␤-and Me9H3-immunoblotted bands was performed using a Bio-Rad GS-800 calibrated densitometer. Data are reported as percentages of HP1␤ (solid bars) or Me9H3 (open bars) densitometry measured in soluble (S) and insoluble (I) fractions. Means Ϯ SE of 3 different experiments are reported. C: nuclear soluble and insoluble proteins from control (lanes 1 and 2) and MADA-3 fibroblasts (lanes 3 and 4) were subjected to SDS-PAGE and Western blotting using antiprelamin A, anti-lamin A/C, and anti-emerin antibodies.
chromatin organization and mechanical integrity of the nucleus, crucial to maintaining cell and tissue integrity during aging (29) . In this context, a recent study provided a molecular link between cellular senescence and heterochromatin structure (33) . These authors showed that senescent human fibroblasts accumulate a distinct chromatin structure enriched with heterochromatin proteins, designated SAHF, that excludes active transcription and is characterized by the accumulation of Me9H3 and HP1 proteins. Interestingly, we observed Hoechstpositive foci highly resembling SAHF in ϳ15% of MADA-1 nuclei with HP1␤ and methylated histone H3 at lysine 9 concentrated in these foci, suggesting a process of accelerated cellular senescence in these cells. In agreement with this observation, we found an increase in senescence-associated ␤-galactosidase staining in MADA cells, which correlates with patient's age (data not shown). Moreover, we demonstrated that HP1␤ and Me9H3 become partially solubilized by Triton X-100 treatment, consistent with the finding that heterochromatin in these cells is partly unstructured. This was also confirmed by the fact that Me9H3 loses its intracellular localization in 30% of MADA-3 nuclei. In accordance with the histone code hypothesis, Me9H3 is required to create highaffinity binding sites for HP1, crucial to promote the formation of higher-ordered heterochromatin structures (4, 13, 47) . This observation may help explain the dramatic loss of heterochromatin areas we observed in MADA nuclei. In fact, the ultrastructural microscopy shows progressive alterations in nuclear architecture in fibroblasts obtained from MADA patients bearing the common R527H mutation.
Focal loss and, in many cases, detachment of peripheral heterochromatin and alteration of nuclear morphology (nuclear envelope invaginations and/or papillary extroflessions), similar to those found in other laminopathies, were observed (2, 8, 15, 19, 26, 32, 34, 40, 41, 44, 45) . These changes, together with the altered distribution of the two major heterochromatin components, Me9H3 and HP1␤ proteins, strongly support the hypothesis that R527H mutation may alter the normal formation of heterochromatin-nuclear lamina protein complex. Chromatin defects observed in MADA nuclei are comparable with those observed in the nuclei from lamin A/C Ϫ/Ϫ mouse fibroblasts (44) and with alterations shown in EDMD, FPLD, and HGPS nuclei (9, 19, 37, 41) . However, at least two features are exclusively found in MADA and HGPS nuclei: the complete absence of heterochromatin areas and the nuclear lamina thickening (present study and Ref. 19 ). Both of these nuclear defects could be related to the accumulation of unprocessed lamin A precursor, as observed in HGPS (14, 19) and MADA cells (present study and Ref. 10). Altered prelamin A processing and defective nuclear envelope organization have also been demonstrated in Zmpste24-deficient mice (6, 38) . Interestingly, Fong et al. (16) recently demonstrated that the accumulation of prelamin A is responsible for many aspects of the diseaseassociated phenotype, including the misshapen nuclei, and that lowering the prelamin A level may modify the evolution of the disease (16) . In this context, notwithstanding the fact that heterozygous R527H cells exhibit nuclear abnormalities (35), we did not observe any significant increase of prelamin A level with respect to age-matched controls (data not shown).
We observed a marked redistribution of LBR in MADA cells. Mislocalization of LBR was also reported in EDMD2 fibroblasts and in myoblasts, suggesting that lamin A/C mutations, directly or indirectly, affect the localization of the nuclear envelope protein LBR (40) . Moreover, several studies have highlighted the importance of the association of LBR with components of the heterochromatin such as HP1 proteins (25, 39, 48) . Therefore, our study provides a link between lamin A mutations and altered chromatin remodeling, supporting a common pathogenetic mechanism. Recent findings suggest that the multisystem nature and the wide spectrum of phenotype variation of several monogenic disorders are attributable to defects of chromatin remodeling (3, 7, 12, 21) . Laminopathies represent an excellent model to investigate the molecular basis of this phenomena. In fact, it is not clear why mutations in LMNA, EMD, and LBR, which are expressed in most cells, cause tissue-specific disorders. On the other hand, it is unclear why different mutations in LMNA cause different diseases (27, 31, 36) . Several hypotheses were suggested to explain their pathogenetic mechanisms. These include the mechanical/structural model and the gene expression model (20) . Although these models are not mutually exclusive, they do not explain the etiological link between an altered nuclear envelope and transcriptional misregulation. Dramatic defects in nuclear envelope structure are evident in cells from patients with EDMD, FPLD, or progerias and in mice carrying engineered mutations in LMNA. In particular, the nuclei show frequent blebbing or "herniations" with evident alterations in nuclear shape, increased separation of the inner and outer nuclear membranes, clustering of nuclear pores, loss of some inner nuclear membrane proteins from one pole of the nucleus, and disruption of the underlying electron-dense heterochromatin (9, 19, 30, 37, 41, 44) . Nuclear envelopes from Lmna Ϫ/Ϫ mice exhibit increased fragility (2, 26, 34) , and, in general, nuclei containing defective lamins may be mechanically more fragile. Our study provides the first evidence of an alteration of heterochromatinassociated protein distribution in laminopathies and allows the first direct correlation between worsening of lamin A defect (precursor protein accumulation) and increasing heterochromatin loss. Provided that HP1␤, LBR, and Me9H3 belong to the same functional complex and all appear affected in MADA cells, our results argue for a role of lamin A in the correct assembly and/or stability of this chromatin-associated complex. Moreover, mislocalization of emerin was also observed in MADA-3 cells, the cells obtained from the oldest patient showing major nuclear defects. It is noteworthy that absence of interaction between emerin and lamin A was previously found in FPLD fibroblasts (9) , which also accumulate prelamin A (10).
The phenotypic variations associated with mutations in the LMNA gene reflect the functional diversity, redundancy, and modulation of the lamin maturation process in different cellular types. As a consequence, the spectrum of mutations that affect lamin-protein interaction could give rise to multiple phenotypes, because each mutation could differentially affect this pathway. Additionally, slight variations in the function of redundant and cooperative pathways could also contribute to the phenotypic diversity. For example, because the regulation of gene expression requires a fine compartmentalization that is supported by chromatin architecture, mutations in different lamin sites could generate an alteration in gene transcription. Our results provide further support for the hypothesis of a regulatory pathway connecting, in sequence, cellular mor-
